Immunobiology · 2025
Predictive value of NKG2A+ NK cell population in diagnosing severe COVID-19 patients.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yang Chunqiu, Qian Rui, Gong Mengtao, Qin Yizu, Zheng Meijuan
Аннотация
OBJECTIVES: To evaluate the predictive value of NKG2A+ natural killer (NK) cells in identifying patients at risk of developing severe COVID-19 and assess the therapeutic potential of NKG2A blockade in restoring NK cell antiviral activity.
METHODS: The association between NKG2A+ NK cells and clinical characteristics was assessed in Omicron-infected patients, and the diagnostic efficacy of NKG2A+ NK cell proportions was evaluated using ROC curves. Additionally, NKG2A blockade experiments were conducted in patients infected with the Wuhan strain.
RESULTS: The proportion of NKG2A+ NK cells was significantly elevated in patients with severe COVID-19 caused by the Omicron variant, particularly among elderly individuals and those with multiple comorbidities. Integrating NKG2A+ NK cell proportions into a laboratory-based model significantly improved the predictive accuracy for severe COVID-19. Patients with NKG2A+ NK cell proportions ≥27 % exhibited lower lymphocyte counts and higher levels of NLR, D-dimer, CRP, LDH, and IL-6. Individuals within this high-NKG2A+ subgroup also had higher expression of inhibitory receptors (TIM3, TIGIT) and lower expression of activation markers (CD69, CD226, NKG2D), along with increased serum levels of TNF, IL-8, IL-10, and CCL5. Importantly, in Wuhan strain-infected patients, NKG2A blockade significantly restored NK cell activity, as shown by increased expression of activation markers NKG2D, CD69, and CD226, indicating a reversal of NK cell dysfunction.
CONCLUSIONS: NKG2A expression contributes to immunosuppression in COVID-19, with NKG2A+ NK cells serving as a diagnostic indicator of disease severity. A cut-off value of 27 % NKG2A+ NK cells may be clinically relevant for stratifying risk.
METHODS: The association between NKG2A+ NK cells and clinical characteristics was assessed in Omicron-infected patients, and the diagnostic efficacy of NKG2A+ NK cell proportions was evaluated using ROC curves. Additionally, NKG2A blockade experiments were conducted in patients infected with the Wuhan strain.
RESULTS: The proportion of NKG2A+ NK cells was significantly elevated in patients with severe COVID-19 caused by the Omicron variant, particularly among elderly individuals and those with multiple comorbidities. Integrating NKG2A+ NK cell proportions into a laboratory-based model significantly improved the predictive accuracy for severe COVID-19. Patients with NKG2A+ NK cell proportions ≥27 % exhibited lower lymphocyte counts and higher levels of NLR, D-dimer, CRP, LDH, and IL-6. Individuals within this high-NKG2A+ subgroup also had higher expression of inhibitory receptors (TIM3, TIGIT) and lower expression of activation markers (CD69, CD226, NKG2D), along with increased serum levels of TNF, IL-8, IL-10, and CCL5. Importantly, in Wuhan strain-infected patients, NKG2A blockade significantly restored NK cell activity, as shown by increased expression of activation markers NKG2D, CD69, and CD226, indicating a reversal of NK cell dysfunction.
CONCLUSIONS: NKG2A expression contributes to immunosuppression in COVID-19, with NKG2A+ NK cells serving as a diagnostic indicator of disease severity. A cut-off value of 27 % NKG2A+ NK cells may be clinically relevant for stratifying risk.